The University of California Davis School of Medicine is the medical school of the University of California, Davis. Although the parent institution is near Davis, California, the medical school is in Sacramento, California.

During the past decade, University of California Davis School of Medicine conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of California Davis School of Medicine" #1 sponsor was "Actelion" with 1 trials, followed by "Inhibrx, Inc." with 1 trials sponsored, "Pfizer" with 1 trials sponsored, "University of California, Davis" with 1 trials sponsored and "University of California, Los Angeles" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of California Davis School of Medicine" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator, "Patient-Centered Outcomes Research Institute" with 1 trials as a collaborator and "Susan G. Komen Breast Cancer Foundation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "University of California Davis School of Medicine" are "AATD" (1 trials), "Alpha-1 Antitrypsin Deficiency" (1 trials), "Breast Cancer" (1 trials), "Cancer of the Prostate" (1 trials) and "Hormone Sensitive Prostate Cancer" (1 trials). Many other conditions were trialed in "University of California Davis School of Medicine" in a lesser frequency.

Most popular intervention types in "University of California Davis School of Medicine" are "Drug" (4 trials), "Behavioral" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bosentan" (1 trials), "Collaborative Connected health, (CCH)" (1 trials), "Control" (1 trials), "Dramatic Reading" (1 trials) and "Enzalutamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of California Davis School of Medicine" are 5 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of California Davis School of Medicine". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in University of California Davis School of Medicine, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of California Davis School of Medicine, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".